List of SBIR/STTR awards granted to ONL Therapeutics
ONL TherapeuticsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to ONL Therapeutics in September, 2018 for $300,202.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42EY029625-01 | Phase I | 300,202 | September 30, 2018 | |||||||
A STTR Phase II contract was awarded to ONL Therapeutics in August, 2020 for $618,183.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42EY029625-02 | Phase II | 618,183 | August 1, 2020 | |||||||
A SBIR Phase II contract was awarded to ONL Therapeutics in September, 2014 for $1,377,371.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44EY022512-02A1 | Phase II | 1,377,371 | September 1, 2014 | |||||||
A SBIR Phase II contract was awarded to ONL Therapeutics in April, 2017 for $1,219,466.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2SB1EY022512-03 | Phase II | 1,219,466 | April 1, 2017 | |||||||
A SBIR Phase I contract was awarded to ONL Therapeutics for $421,640.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EY022512-01 | Phase I | 421,640 |
